TY  - GEN
AU  - Wassmann,B
AU  - Klein,S A
AU  - Scheuring,U
AU  - Pfeifer,H
AU  - Martin,H
AU  - Gschaidmeier,H
AU  - Hoelzer,D
AU  - Ottmann,O G
TI  - Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation
SN  - 0268-3369
PY  - 2001///1214
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Agents, Alkylating
KW  - therapeutic use
KW  - Benzamides
KW  - Bone Marrow Transplantation
KW  - Colitis
KW  - chemically induced
KW  - Combined Modality Therapy
KW  - Enzyme Inhibitors
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - etiology
KW  - Graft vs Leukemia Effect
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Hydroxyurea
KW  - Imatinib Mesylate
KW  - Immunosuppression Therapy
KW  - Interferon-alpha
KW  - Leukemia, Myeloid, Accelerated Phase
KW  - drug therapy
KW  - Leukemia, Myeloid, Chronic-Phase
KW  - Lymphocyte Transfusion
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm, Residual
KW  - Neutropenia
KW  - Piperazines
KW  - Pyrimidines
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1703222
ER  -